PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2014 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$1.45M, a 19.3% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$7.67M, a 5.91% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.02M, a 12.3% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.14M, a 91.2% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.78M, a 8.59% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$7.67M -$1.45M +$345K +19.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$8.02M -$2.21M -$504K -29.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$7.51M -$2.15M +$543K +20.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$8.05M -$1.86M +$97.6K +4.97% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 -$8.15M -$1.79M +$991K +35.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$9.14M -$1.7M +$386K +18.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$9.53M -$2.69M +$396K +12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$9.92M -$1.96M -$1.99M -7309% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$7.94M -$2.78M -$3.15M -851% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$4.78M -$2.09M -$2.81M -392% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$1.98M -$3.09M +$690K +18.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$2.67M $27.2K -$628K -95.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2.04M $371K +$3.19M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$5.23M $715K +$5.27M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$10.5M -$3.78M -$1.75M -86.6% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-20
Q2 2020 -$8.75M $655K +$2.68M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-20
Q1 2020 -$11.4M -$2.82M -$1.41M -100% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-27
Q4 2019 -$10M -$4.56M -$3.45M -311% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
Q3 2019 -$6.57M -$2.03M -$430K -27% Jul 1, 2019 Sep 30, 2019 10-K/A 2021-04-23
Q2 2019 -$6.14M -$2.03M -$1.47M -262% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 -$4.67M -$1.41M -$336K -31.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-18
Q4 2018 -$4.34M -$1.11M +$927K +45.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-22
Q3 2018 -$5.26M -$1.6M -$877K -122% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.39M -$560K -$53.4K -10.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$4.33M -$1.07M -$473K -78.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$3.86M -$2.04M -$1.29M -172% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$2.57M -$718K -$358K -99.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.21M -$506K -$245K -94.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$1.97M -$601K -$366K -156% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.6M -$747K -$679K -985% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$924K -$360K -$247K -219% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$677K -$261K -$148K -132% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$529K -$235K -$171K -268% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$358K -$68.9K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$113K -$37.7K -50.4% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$113K -$105K -1369% Apr 1, 2015 Jun 30, 2015 10-Q 2016-11-14
Q1 2015 -$63.8K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 -$74.9K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$7.67K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.